Gov. Evers’ Task Force Should Avoid Drug-Depriving Decisions

By Chris Rochester - September 24, 2019

Drug Prices, Health Care, Health Care Costs, ICER, QALY

By Brett Healy – While the cost of drugs is certainly a serious concern, free market advocates, and humans in general, worry that efforts to control drug costs based on a cost-benefit analysis of certain therapies will literally lead the government to make life or death decisions for us. Read More Gov. Evers’ Task Force Should Avoid Drug-Depriving Decisions

Americans Should Be Wary of Embracing Socialist-Style Price Controls

By Chris Rochester - July 19, 2019

Congress, Drug Costs, Health Care Costs, ICER, Prescription Drugs, President Trump, QALY, Quality Adjusted Life Years

Perspective by Chris Rochester – President Trump has made reducing the price of prescription drugs a cornerstone of his presidency, and that effort continues largely under the radar in Washington. It’s a worthwhile effort, but Trump and Congress should be wary of embracing the type of inhumane, socialist-style price controls adopted in other countries. Read More Americans Should Be Wary of Embracing Socialist-Style Price Controls

Issue Brief: Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology

By Chris Rochester - April 23, 2019

Dr. William Smith, Drug Prices, Drugs, Gov. Tony Evers, ICER, Institute of Clinical and Economic Review, Out of Pocket Drugs, Pioneer Institute, Prescriptions, Quality-Adjusted Life Year

By Chris Rochester – The quality-adjusted life year is a metric being pushed by an organization called the Institute of Clinical and Economic Review (ICER). Essentially, this highly dubious, socialist-style methodology attempts to calculate how much an additional year of life for a sick person seeking a particular treatment is worth to society. Read More Issue Brief: Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology